Lindsey Criswell MD, MPH
University of California-San Francisco, CA
Genetic predictors of thrombosis in systemic lupus erythematosus
Keith Elkon, MD
University of Washington-Seattle, WA
Lysis of Immunostimulatory Nucleoproteins in SLE
Shu Man Fu MD, PhD
University of Virginia-Charlottesville, VA
Identification of Genes Conferring End-Organ Resistance in Lupus Nephritis
Sarah Gaffen, PhD
SUNY University at Buffalo-Buffalo, NY
IL-17RC: A novel target for anti-cytokine therapy
Bevra Hahn, MD
University of California, Los Angeles-Los Angeles, CA
Novel Target for Identification and Treatment of Atherosclerosis in SLE
John Harley, MD
Oklahoma Medical Research Foundation-Oklahoma City, OK
GENES FROM SLEGEN, THE LUPUS GENETICS CONSORTIUM
Marianthi Kiriakidou, MD
University of Pennsylvania-Philadelphia, PA
Profile and function of B-cell specific microRNAs in a murine SLE model
Ann Marshak-Rothstein, PhD
Boston University-Boston, MA
Activation and Inhibition of TRL Activity in Autoreactive B Cells
Chandra Mohan, PhD
UT Southwestern Medical Center-Dallas, TX
Kallikreins in lupus nephritis
John Mountz, MD
University of Alabama at Birmingham-Birmingham, AL
Disruption of autoreactive germinal centers as a novel therapy for lupus
Fred Perrino, PhD
Wake Forest University Health Sciences-Winston-Salem, NC
Targeting Dysfunctional Nucleases in Lupus
Shiv Pillai PhD, MBBS
Massachusetts General Hospital (The General Hospital Corp.)-Boston, MA
SIAE and susceptibility to lupus and rheumatoid arthritis
Ian Rifkin MD, PhD
Boston Medical Center Corporation-Boston, MA
PPAR Gamma and Adiponectin in Lupus Nephritis and Atherosclerosis
|
|